Side Effects of Central Analgesic Drugs

Reference work entry

Abstract

Morphine, as the prototype of a central analgesic drug, has characteristic adverse effects that are relevant to the treatment of patients. Important among these effects are the following:

Keywords

Conditioned Place Preference Place Preference Physical Dependence Opioid Agonist Discriminative Stimulus Effect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References and Further Reading

  1. Aceto MD (1990) Assessment of physical dependence techniques for the evaluation of abused drugs. In: Adler MW, Cowan A (eds) Testing and evaluation of drugs of abuse, vol 6, Modern methods in pharmacology. Wiley, New York, pp 67–79Google Scholar
  2. Acquas E, Di Chiara G (1994) D1 receptor blockade stereospecifically impairs the acquisition of drug-conditioned place preference and place aversion. Behav Pharmacol 5:555–560PubMedCrossRefGoogle Scholar
  3. Acquas E, Carboni E, Garau L, Di Chiara G (1990) Blockade of acquisition of drug-conditioned place aversion by 5-HT3antagonists. Psychopharmacology 100:459–463PubMedCrossRefGoogle Scholar
  4. Amalric M, Cline EJ, Martinez JL Jr, Bloom FE, Koob GF (1987) Rewarding properties of β-endorphin as measured by conditioned place preference. Psychopharmacology 91:14–19PubMedCrossRefGoogle Scholar
  5. Bals-Kubik R, Herz A, Shippenberg TS (1988) β-endorphin-(1–27) is a naturally occurring antagonist of the reinforcing effects of opioids. Naunyn-Schmiedeberg’s Arch Pharmacol 338:392–396Google Scholar
  6. Bals-Kubik R, Shippenberg TS, Herz A (1990) Involvement of central μ and δ opioid receptors in mediating the reinforcing effects of β-endorphin in the rat. Eur J Pharmacol 175:63–69PubMedCrossRefGoogle Scholar
  7. Balster RL, Prescott WR (1990) Δ9-Tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication. Neurosci Behav Rev 16:55–62CrossRefGoogle Scholar
  8. Bechara A, Van der Kooy D (1987) Kappa receptors mediate the peripheral aversive effects of opiates. Pharmacol Biochem Behav 28:227–233PubMedCrossRefGoogle Scholar
  9. Bechtholt AJ, Gremel CM, Cunningham CL (2004) Handling blocks expression of conditioned place aversion but not conditioned place preference by ethanol in mice. Pharmacol Biochem Behav 79:739–744PubMedCrossRefGoogle Scholar
  10. Bertalmio AJ, Woods JH (1987) Differentiation between μ and κ receptor mediated effects in opioid drug discrimination: apparent pA2analysis. J Pharmacol Exp Ther 243:591–598PubMedGoogle Scholar
  11. Bertalmio AJ, Herling S, Hampton RY, Winger G, Woods JH (1982) A procedure for rapid evaluation of the discriminative stimulus effects of drugs. J Pharmacol Methods 7:289–299PubMedCrossRefGoogle Scholar
  12. Bormann NM, Cunningham CL (1998) Ethanol-induced conditioned place aversion in rats: effects of interstimulus interval. Pharmacol Biochem Behav 59:427–432PubMedCrossRefGoogle Scholar
  13. Bozarth MA (1987) Intracranial self-administration procedures for the assessment of drug reinforcement. In: Bozarth MA (ed) Methods for assessing the reinforcing properties of abused drugs. Springer, New York/Berlin/Heidelberg, pp 178–187CrossRefGoogle Scholar
  14. Brady JV, Griffiths RR, Hienz RD, Ator NA, Lukas SE, Lamb RJ (1987) Assessing drugs for abuse liability and dependence potential in laboratory primates. In: Bozarth MA (ed) Methods for assessing the reinforcing properties of abused drugs. Springer, New York/Berlin/Heidelberg, pp 45–85CrossRefGoogle Scholar
  15. Brandt MR, France CP (1998) Chronic l-alpha acetylmethadol in rhesus monkeys: discriminative stimulus and other behavioral measures of dependence and withdrawal. J Pharmacol Exp Ther 287:1029–1037PubMedGoogle Scholar
  16. Broadbent J, Muccino KJ, Cunningham CL (2002) Ethanol-induced conditioned taste aversion in 15 inbred mouse strains. Behav Neurosci 116:138–148PubMedCrossRefGoogle Scholar
  17. Brockwell NT, Beninger RJ (1996) The differential role of A1 and A2 adenosine subtypes in locomotor activity and place conditioning in rats. Behav Pharmacol 7:373–383PubMedCrossRefGoogle Scholar
  18. Brockwell NT, Eikelboom R, Beninger RJ (1991) Caffeine-induced place and taste conditioning: production of dose-dependent preference and aversion. Pharmacol Biochem Behav 38:513–517PubMedCrossRefGoogle Scholar
  19. Brockwell NT, Ferguson DS, Beninger RJ (1996) A computerized system for the simultaneous monitoring of place conditioning and locomotor activity in rats. J Neurosci Methods 64:227–232PubMedCrossRefGoogle Scholar
  20. Buckett WR (1964) A new test for morphine-like physical dependence (addiction liability) in rats. Psychopharmacologia 6:410–416PubMedCrossRefGoogle Scholar
  21. Butelman ER, France CP, Woods JH (1993) Apparent pA2analysis on the respiratory depressant effects of alfentanil, etonitazene, ethylketocyclazocine (EKC) and Mr2033 in rhesus monkeys. J Pharmacol Exp Ther 264:145–151PubMedGoogle Scholar
  22. Calcagnetti DJ, Quatrella LA, Schechter MD (1996) Olfactory bulbectomy disrupts the expression of cocaine-induced conditioned place preference. Physiol Behav 59:597–604PubMedCrossRefGoogle Scholar
  23. Carboni E, Acquas E, Leone P, di Chiara G (1989) 5-HT3receptor antagonists block morphine- and nicotine- but not amphetamine-induced award. Psychopharmacology 97:175–178PubMedCrossRefGoogle Scholar
  24. Chan PC (2000) NTP toxicity studies of carisoprodol (CAS No. 78-44-4) administered by Gavage to F344/N rats and B6C3F1 mice. Toxic Rep Ser (56):1–G14Google Scholar
  25. Chaperon F, Thiébot MH (1996) Effects of dopaminergic D3-receptor-preferring ligands on the acquisition of place conditioning in rats. Behav Pharmacol 7:105–109PubMedCrossRefGoogle Scholar
  26. Collier HOJ, Cuthbert NJ, Francis DL (1979) Effects of time and drug concentration on the induction of responsiveness to naloxone in guinea pig ileum exposed to normorphine in vitro. Br J Pharmacol 69:332P–333PGoogle Scholar
  27. Colpaert FC (1987) Drug discrimination: methods of manipulation, measurement, and analysis. In: Bozarth MA (ed) Methods for assessing the reinforcing properties of abused drugs. Springer, New York/Berlin/Heidelberg, pp 341–372CrossRefGoogle Scholar
  28. Colpaert FC, Janssen PAJ (1984) Agonist and antagonist effects of prototype opiate drugs in rats discrimination fentanyl from saline: characteristics of partial generalization. J Pharmacol Exp Ther 220:193–199Google Scholar
  29. Contarino A, Zanotti A, Drago F, Natolino F, Lipartiti M, Giusti P (1997) Conditioned place preference: no tolerance to the rewarding properties of morphine. Naunyn-Schmiedeberg’s Arch Pharmacol 355:589–594CrossRefGoogle Scholar
  30. Cowan A, Zhu XZ, Mosberg HI, Omnaas JR, Porreca F (1988) Direct dependence studies in rats with agents selective for different types of opioid receptor. J Pharmacol Exp Ther 246:950–955PubMedGoogle Scholar
  31. Cruz SL, Salazar LA, Villarreal JE (1991) A methodological basis for improving the reliability of measurements of opiate abstinence responses in the guinea pig ileummade dependent in vitro. J Pharmacol Methods 25:329–342PubMedCrossRefGoogle Scholar
  32. Davies AM, Parker LA (1993) Fenfluramine-induced place aversion in a three-choice apparatus. Pharmacol Biochem Behav 44:595–600PubMedCrossRefGoogle Scholar
  33. Del Poso E, Barrios M, Baeyens JM (1996) The NMDA receptor antagonist dizocilpine (MK-801) stereoselectively inhibits morphine-induced place preference in mice. Psychopharmacology 125:209–213CrossRefGoogle Scholar
  34. Deneau GA (1964) Pharmacological techniques for evaluating addiction liability of drugs. In: Nodine JH, Siegler PE (eds) Animal and clinical pharmacologic techniques in drug evaluation. Year Book Medical Publication, Chicago, pp 406–410Google Scholar
  35. Deneau GA, Seevers MH (1964) Drug dependence. In: Laurence DR, Bacharach AL (eds) Evaluation of drug activities: pharmacometrics. Academic, London/New York, pp 167–179Google Scholar
  36. Deneau G, Yanagita T, Seevers MH (1969) Self-administration of psychoactive substances by the monkey. Psychopharmacologia 16:30–48PubMedCrossRefGoogle Scholar
  37. Dykstra LA, Gmerek DE, Winger G, Woods JH (1987) Kappa opioids in rhesus monkeys. I. Diuresis, sedation, analgesia and discriminative stimulus effects. J Pharmacol Exp Ther 242:413–420PubMedGoogle Scholar
  38. Dykstra LA, Bertalmio AJ, Woods JH (1988) Discriminative and analgesic effects of mu and kappa opioids: in vivo pA2analysis. In: Colpaert FC, Balster RL (eds) Transduction mechanisms of drug stimuli, vol 4, Psychopharmacology series. Springer, Berlin/Heidelberg/New York, pp 107–121CrossRefGoogle Scholar
  39. France CP (1995) A sensitive, efficient drug discrimination procedure for studying kappa antagonists in rhesus monkeys. Analgesia 1:421–424Google Scholar
  40. France CP, Woods JH (1993) U-50488, saline, naltrexone discrimination in U-50,488 treated pigeons. Behav Pharmacol 4:509–516PubMedCrossRefGoogle Scholar
  41. France CP, Medzihradsky F, Woods JH (1994) Comparison of kappa opioids in rhesus monkeys: behavioral effects and binding affinities. J Pharmacol Exp Ther 268:47–58PubMedGoogle Scholar
  42. France CP, Gerak LR, Winger GD, Medzihradsky F, Bagley JR, Brockunier LL, Woods JH (1995) Behavioral effects and receptor binding affinities of fentanyl derivatives in rhesus monkeys. J Pharmacol Exp Ther 274:17–28PubMedGoogle Scholar
  43. Frisch C, Hasenöhrl RU, Mattern CM, Häcker R, Huston JP (1995) Blockade of lithium chloride-induced conditioned place aversion as a test for antiemetic agents: comparison of metoclopramide with combined extracts of Zingiber officinale and Ginkgo biloba. Pharmacol Biochem Behav 52:321–327PubMedCrossRefGoogle Scholar
  44. Gabriel KI, Cunningham CL, Finn DA (2004) Allopregnanolone does not influence ethanol-induced conditioned place preference in DBA/2J mice. Psychopharmacology 176:50–56PubMedCrossRefGoogle Scholar
  45. Gaiardi M, Bartoletti M, Bacchi A, Gubellini C, Babbibi M (1997) Motivational properties of buprenorphine as assessed by place and taste conditioning in rats. Psychopharmacology 130:104–108PubMedCrossRefGoogle Scholar
  46. Garcia J, Kimmeldorf DJ, Koelling RA (1955) Conditioned taste aversion to saccharin resulting from exposure to gamma irradiation. Science 122:157–158PubMedGoogle Scholar
  47. Gatley SJ, Meehan SM, Chen R, Pan D-F, Schechter MD, Dewey SL (1996) Place preference and microdialysis studies with two derivatives of methylphenidate. Life Sci 58:PL345–PL352PubMedCrossRefGoogle Scholar
  48. Geller EB, Adler MW (1990) Drugs of abuse and body temperature. In: Adler MW, Cowan A (eds) Testing and evaluation of drugs of abuse, vol 6, Modern methods in pharmacology. Wiley, New York, pp 101–109Google Scholar
  49. Gellert VF, Holtzman SG (1978) Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphing drinking solutions. J Pharmacol Exp Ther 205:536–546PubMedGoogle Scholar
  50. Gerak LR, Butelman ER, Woods JH, France CP (1994) Antinociceptive and respiratory effects of nalbuphine in rhesus monkeys. J Pharmacol Exp Ther 271:993–999PubMedGoogle Scholar
  51. Glassman JM (1971) Agents with analgesic activity and dependence liability. In: Turner RA, Hebborn P (eds) Screening methods in pharmacology, vol II. Academic, London/New York, pp 227–248Google Scholar
  52. Gmerek DE, Dykstra LA, Woods JH (1987) Kappa opioids in rhesus monkeys. III. Dependence associated with chronic administration. J Pharmacol Exp Ther 242:428–436PubMedGoogle Scholar
  53. Gutierrez T, Crystal JD, Zvonok AM, Makriyannis A, Hohmann AG (2011) Self-medication of a cannabinoid CB(2) agonist in an animal model of neuropathic pain. Pain 152(9):1976–1987PubMedCrossRefGoogle Scholar
  54. Hein DW, Young AM, Herling S, Woods JH (1981) Pharmacological analysis of the discriminative stimulus characteristics of ethylketazocine in the rhesus monkey. J Pharmacol Exp Ther 218:7–15PubMedGoogle Scholar
  55. Herling S, Woods JH (1981) Discriminative stimulus effects of narcotics: evidence for multiple receptor-mediated actions. Life Sci 28:1571–1584PubMedCrossRefGoogle Scholar
  56. Higgins GA, Joharchi N, Sellers EM (1993) Behavioral effects of the 5-hydroxytryptamine3receptor agonists 1-phenylbiguanide and m-chlorophenylbiguanide in rats. J Pharmacol Exp Ther 264:1440–1449PubMedGoogle Scholar
  57. Hoffman DC (1989) The use of place conditioning in studying the neuropharmacology of drug reinforcement. Brain Res Bull 23(4–5):373–387PubMedCrossRefGoogle Scholar
  58. Hoffman DC, Donovan H (1995) Effects of typical, atypical, and novel antipsychotic drugs on amphetamine-induced place conditioning in rats. Drug Dev Res 36:193–198CrossRefGoogle Scholar
  59. Hoffmeister F (1979) Preclinical evaluation of reinforcing and aversive properties of analgesics. In: Beers RF, Bassett EG (eds) Mechanics of pain and analgesic compounds. Raven, New York, pp 447–466Google Scholar
  60. Hoffmeister F (1988) A comparison of the stimulus effects of codeine in rhesus monkeys under the contingencies of a two lever discrimination task and a cross self-administration paradigm: tests of generalization to pentazocine, buprenorphine, tilidine, and different doses of codeine. Psychopharmacology 94:315–320PubMedCrossRefGoogle Scholar
  61. Holtzman SG (1983) Discriminative stimulus properties of opioid agonists and antagonists. In: Cooper SJ (ed) Theory in psychopharmacology, vol 2. Academic, London, p 145Google Scholar
  62. Holtzman SG (1990) Discriminative stimulus effects of drugs: relationship to potential for abuse. In: Adler MW, Cowan A (eds) Testing and evaluation of drugs of abuse, vol 6, Modern methods in pharmacology. Wiley, New York, pp 193–210Google Scholar
  63. Holtzman SB, Villarreal JE (1969) Morphine dependence and body temperature in rhesus monkeys. J Pharmacol Exp Ther 166:124–133Google Scholar
  64. Howell LL, Bergman J, Morse WH (1988) Effects of levorphanol and several kappa-selective opioids on respiration and behavior in rhesus monkeys. J Pharmacol Exp Ther 245:364–372PubMedGoogle Scholar
  65. Iwamoto ET (1988) Dynorphin A [1–17] induces ‘reward’ in rats in the place conditioning paradigm. Life Sci 43:503–508PubMedCrossRefGoogle Scholar
  66. Jarbe TU, Swedberg MD (1998) Discriminative stimulus functions of CNS sedative drugs assessed by drug versus drug discrimination procedures in gerbils. Psychopharmacology 135:201–212PubMedCrossRefGoogle Scholar
  67. Johnson-Davis KL, Hanson GR, Keefe KA (2003) Lack of effect of kappa-opioid receptor agonism on long-term methamphetamine-induced neurotoxicity in rats. Neurotox Res 5(4):273–281PubMedCrossRefGoogle Scholar
  68. Kalant H, Khanna JM (1990) Methods for the study of tolerance. In: Adler MW, Cowan A (eds) Testing and evaluation of drugs of abuse, vol 6, Modern methods in pharmacology. Wiley, New York, pp 43–66Google Scholar
  69. Katz JL (1986) Effects of clonidine and morphine on opioid withdrawal in rhesus monkeys. Psychopharmacology 88:392–397PubMedCrossRefGoogle Scholar
  70. Kest B, Palmese CA, Hopkins E, Adler M, Juni A, Mogil JS (2002) Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence. Neuroscience 115:463–469PubMedCrossRefGoogle Scholar
  71. Khanna JM, Mayer JM, Lê AD, Kalant H (1984) Differential response to ethanol, pentobarbital and morphine in mice specially bred for ethanol sensitivity. Alcohol 1:447–451PubMedCrossRefGoogle Scholar
  72. Khroyan TV, Baker DA, Neisewander JL (1995) Dose-dependent effects of the D3-preferring agonist 7-OH-DPAT on motor behaviors and place conditioning. Psychopharmacology 122:351–357PubMedCrossRefGoogle Scholar
  73. Khroyan TV, Fuchs RA, Baker DA, Neisewander JL (1997) Effects of D3-preferring agonists 7-OH-PIPAT and PD-128,907 on motor behaviors and place conditioning. Behav Pharmacol 8:65–74PubMedCrossRefGoogle Scholar
  74. Kilic FS, Dogan AE, Baydemir C, Erol K (2011) The acute effects of mirtazapine on pain related behavior in healthy animals. Neurosciences (Riyadh) 16(3):217–223Google Scholar
  75. Kitaichi K, Noda Y, Hasegawa T, Furukawa H, Nabeshima T (1996) Acute phencyclidine induces aversion, but repeated phencyclidine induces preference in the place conditioning test in rats. Eur J Pharmacol 318:7–9PubMedCrossRefGoogle Scholar
  76. Kornetsky C, Bain B (1990) Brain-stimulation reward: a model for drug-induced euphoria. In: Adler MW, Cowan A (eds) Testing and evaluation of drugs of abuse, vol 6, Modern methods in pharmacology. Wiley, New York, pp 67–79Google Scholar
  77. Kosten TA (1994) Clonidine attenuates conditioned aversion produced by naloxone-precipitated opiate withdrawal. Eur J Pharmacol 254:59–63PubMedCrossRefGoogle Scholar
  78. Lal H, Sherman GT (1980) Interceptive discriminative stimuli in the development of CNS drugs and a case of an animal model of anxiety. Annu Rep Med Chem 15:51–58CrossRefGoogle Scholar
  79. Langerman L, Zakowski MI, Piskoun B, Grant GJ (1995) Hot plate versus tail flick: evaluation of acute tolerance to continuous morphine infusion in the rat model. J Pharmacol Toxicol Methods 34:23–27PubMedCrossRefGoogle Scholar
  80. Lepore M, Vorel SR, Lowinson J, Gardner EL (1995) Conditioned place preference induced by Δ9-tetrahydrocannabinol: comparison with cocaine, morphine, and food award. Life Sci 56:2073–2080PubMedCrossRefGoogle Scholar
  81. Liguori A, Morse WH, Bergman J (1996) Respiratory effects of opioid full and partial agonists in rhesus monkeys. J Pharmacol Exp Ther 277:462–472PubMedGoogle Scholar
  82. Ling GSF, Spiegel K, Nishimura S, Pasternack GW (1983) Dissociation of morphine’s analgesic and respiratory depressant actions. Eur J Pharmacol 86:478–488Google Scholar
  83. Ling GSF, Spiegel K, Lockhart SH, Pasternack GW (1985) Separation of opioid analgesia from respiratory depression: evidence for different receptor mechanisms. J Pharmacol Exp Ther 232:149–155PubMedGoogle Scholar
  84. Littmann K, Heredia JM, Hoffmeister F (1979) Eine neue methode zur enteralen verabreichung von psychotrop wirksamen substanzen beim rhesusaffen. Arzneim Forsch/Drug Res 29:1888–1890Google Scholar
  85. Locke KW, Gorney B, Cornfeldt M, Fielding S (1991) Comparison of the stimulus effects of ethylketocyclazocine in Fischer and Sprague-Dawley rats. Drug Dev Res 23:65–73CrossRefGoogle Scholar
  86. Mamoon AM, Barnes AM, Ho IK, Hoskins B (1995) Comparative rewarding properties of morphine and butorphanol. Brain Res Bull 38:507–511PubMedCrossRefGoogle Scholar
  87. Marcus R, Kornetsky C (1974) Negative and positive intracranial thresholds: effects of morphine. Psychopharmacologia 38:1–13CrossRefGoogle Scholar
  88. Martellotta MC, Fattore L, Cossu G, Fratta W (1997) Rewarding properties of gamma-hydroxybutyric acid: an evaluation through place preference paradigm. Psychopharmacology 132:1–5PubMedCrossRefGoogle Scholar
  89. Martin WR, Eades CG, Thompson WO, Thompson JA, Flanary HG (1974) Morphine physical dependence in the dog. J Pharmacol Exp Ther 189:759–771PubMedGoogle Scholar
  90. Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE (1976) The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197:517–532PubMedGoogle Scholar
  91. Martin-Iverson MT, Reimer AR (1996) Classically conditioned motor effects do not occur with cocaine in an unbiased conditioned place preferences procedure. Behav Pharmacol 7:303–314PubMedCrossRefGoogle Scholar
  92. Martin-Iverson MT, Reimer AR, Sharma S (1997) Unbiased cocaine conditioned place preferences (CPP) obscures conditioned locomotion, and nimodipine blockade of cocaine CPP is due to conditioned place aversions. Psychopharmacology 130:327–333PubMedCrossRefGoogle Scholar
  93. McDougal JN, Marques PR, Burks TF (1983) Restraint alters the thermic response to morphine by postural interference. Pharmacol Biochem Behav 18:495–499PubMedCrossRefGoogle Scholar
  94. Meert TF, Janssen PAJ (1989) Psychopharmacology of ritanserin: comparison with chlordiazepoxide. Drug Dev Res 18:119–144CrossRefGoogle Scholar
  95. Meert TF, de Haes P, Janssen PAJ (1989) Risperidone (R 64 766), a potent and complete LSD antagonist in drug discrimination by rats. Psychopharmacology 97:206–212PubMedCrossRefGoogle Scholar
  96. Meert TF, de Haes LAJ, Vermote PCM, Janssen PAJ (1990) Pharmacological validation of ritanserin and risperidone in the drug discrimination procedure in the rat. Drug Dev Res 19:353–373CrossRefGoogle Scholar
  97. Meisch RA, Carroll ME (1987) Oral drug self-administration: drugs as reinforcers. In: Bozarth MA (ed) Methods for assessing the reinforcing properties of abused drugs. Springer, New York/Berlin/Heidelberg, pp 143–160CrossRefGoogle Scholar
  98. Mucha RF, Herz A (1985) Motivational properties of kappa and mu-opioid agonists studied with place and taste preference conditioning procedures. Psychopharmacology 82:241–245CrossRefGoogle Scholar
  99. Mucha RF, Iversen SD (1984) Reinforcing properties of morphine and naloxone revealed by conditioned place preferences: a procedural examination. Psychopharmacology 82:241–247PubMedCrossRefGoogle Scholar
  100. Murphy DJ, Joran ME, Grando JC (1995) A non-invasive method for distinguishing central from peripheral nervous system effect of respiratory depressant drugs in conscious rats. Gen Pharmacol 26:569–575PubMedCrossRefGoogle Scholar
  101. Nelson RB, Elliott HW (1967) A comparison of some central effects of morphine, morphinone and thebaine on rats and mice. J Pharmacol Exp Ther 155:516–520PubMedGoogle Scholar
  102. Olds J (1979) Drives and reinforcements: behavioral studies of hypothalamic functions. Raven, New YorkGoogle Scholar
  103. Olds J, Killam KF, Bachy-Rita P (1956) Self-stimulation of the brain used as screening method for tranquilizing drugs. Science 124:265–266PubMedCrossRefGoogle Scholar
  104. Overton DA (1987) Applications and limitations of the drug discrimination method for the study of drug abuse. In: Bozarth MA (ed) Methods for assessing the reinforcing properties of abused drugs. Springer, New York/Berlin/Heidelberg, pp 291–340CrossRefGoogle Scholar
  105. Pain L, Oberling P, Sandner G, Di Scala G (1997) Effect of midazolam on propofol-induced positive affective state assessed by place conditioning in rats. Anesthesiology 87:935–943PubMedCrossRefGoogle Scholar
  106. Papp M, Moryl E, Maccechini ML (1996) Differential effects of agents acting at various sites of the NMDA receptor complex in a place preference conditioning model. Eur J Pharmacol 317:191–196PubMedCrossRefGoogle Scholar
  107. Parker LA (1996) LSD produces place preference and flavor avoidance but does not produce flavor aversion in rats. Behav Neurosci 110:503–508PubMedCrossRefGoogle Scholar
  108. Pasternak GW (1987) Opioid receptors. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven, New York, pp 281–288Google Scholar
  109. Paxinos G, Watson C (1982) The rat in stereotaxic coordinates. Academic, SidneyGoogle Scholar
  110. Perks SM, Clifton PG (1997) Reinforcer revaluation and conditioned place preference. Physiol Behav 61:1–5PubMedCrossRefGoogle Scholar
  111. Pierce TL, Raper C (1995) The effects of laboratory handling procedures on naloxone-precipitated withdrawal behavior in morphine-dependent rats. J Pharmacol Toxicol Methods 34:149–155PubMedCrossRefGoogle Scholar
  112. Pierce TL, Hope W, Raper C (1996) The induction and quantitation of methadone dependence in the rat. J Pharmacol Toxicol Methods 36:137–146PubMedCrossRefGoogle Scholar
  113. Porsolt RD, Lemaire M, Dürmüller N, Roux S (2002) New perspectives in CNS safety pharmacology. Fundam Clin Pharmacol 16(3):197–207PubMedCrossRefGoogle Scholar
  114. Rahn EJ, Thakur GA, Wood JA, Zvonok AM, Makriyannis A, Hohmann AG (2011) Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: antinociception without central nervous system side-effects. Pharmacol Biochem Behav 98(4):493–502PubMedCrossRefGoogle Scholar
  115. Riba P, Ben Y, Smith AP, Furst S, Lee NM (2002) Morphine tolerance in spinal cord is due to interaction between mu- and delta-receptors. J Pharmacol Exp Ther 300:265–272PubMedCrossRefGoogle Scholar
  116. Rodríguez R, Luján M, Campos AE, Chorné R (1978) Morphine-dependence in the isolated guinea pig ileum and its modification by p-chlorophenylalanine. Life Sci 23:913–920PubMedCrossRefGoogle Scholar
  117. Saelens JK, Granat FR, Sawyer WK (1971) The mouse jumping test: a simple screening method to estimate the physical dependence capacity of analgesics. Arch Int Pharmacodyn 190:213–218PubMedGoogle Scholar
  118. Sante AB, Nobre MJ, Brandao ML (2000) Place aversion induced by blockade of mu or activation of kappa opioid receptors in the dorsal periaqueductal gray matter. Behav Pharmacol 11:583–589PubMedCrossRefGoogle Scholar
  119. Sañudo-Peña CM, Tsou K, Delay ER, Hohman AG, Force M, Walker JM (1997) Endogenous cannabinoids as an aversive or counter-rewarding system in the rat. Neurosci Lett 223:125–128PubMedCrossRefGoogle Scholar
  120. Schechter MD, Meehan SM (1994) Conditioned place aversion produced by dopamine release inhibition. Eur J Pharmacol 260:133–137PubMedCrossRefGoogle Scholar
  121. Seevers MH (1963) Opiate addiction in the monkey. I. Methods of study. J Pharmacol Exp Ther 56:147–156Google Scholar
  122. Seevers MH, Deneau GA (1963) Physiological aspects of tolerance and physical dependence. In: Root WS, Hoffman FG (eds) Physiological pharmacology, vol I. Academic, New York/London, p 565Google Scholar
  123. Self DW, Stein L (1992) Receptor subtypes in opioid and stimulation reward. Pharmacol Toxicol 70:87–94PubMedCrossRefGoogle Scholar
  124. Shannon HE, Holtzman SG (1976) Evaluation of the discriminative effects of morphine in the rat. J Pharmacol Exp Ther 198:64–65Google Scholar
  125. Shannon HE, Holtzman SG (1986) Blockade of the discriminative effects of morphine by naltrexone and naloxone. Psychopharmacologia 50:119–124CrossRefGoogle Scholar
  126. Shelton KL, Dukat M, Allan AM (2004) Effects of 5-HT3receptor over-expression on the discriminative stimulus effects of ethanol. Alcohol Clin Exp Res 28:1161–1171PubMedCrossRefGoogle Scholar
  127. Sherman G, Lal H (1979) Discriminative stimulus properties of pentylenetetrazol and begrimide: some generalization and antagonism tests. Psychopharmacology 64:315–319CrossRefGoogle Scholar
  128. Sherman GT, Lal H (1980) Generalization and antagonism studies with convulsants, GABAergic and anticonvulsant drugs in rats trained to discriminate pentylenetetrazol from saline. Neuropharmacology 19:473–479CrossRefGoogle Scholar
  129. Sherman GT, Miksic S, Lal H (1979) Lack of tolerance development to benzodiazepines in antagonism of the pentylenetetrazol discriminative stimulus. Pharmacol Biochem Behav 10:795–797CrossRefGoogle Scholar
  130. Shippenberg TS, Herz A (1987) Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of μ- and κ-opioid agonists. Brain Res 436:169–172PubMedCrossRefGoogle Scholar
  131. Shippenberg TS, Bals-Kubik R, Herz A (1987) Motivational properties of opioids: evidence that an activation of δ-receptors mediate reinforcement processes. Brain Res 436:234–239PubMedCrossRefGoogle Scholar
  132. Smith FL, Javed RR, Elzey MJ, Dewey WL (2003) The expression of a high level of morphine antinociceptive tolerance in mice involves both PKC and PKA. Brain Res 985:78–88PubMedCrossRefGoogle Scholar
  133. Steinpreis RE, Kramer MA, Mix KS, Piwowarczyk MC (1995) The effects of MK801 on place conditioning. Neurosci Res 22:427–430PubMedCrossRefGoogle Scholar
  134. Steinpreis RE, Rutell AL, Parrett FA (1996) Methadone produces conditioned place preference in the rat. Pharmacol Biochem Behav 54:339–431PubMedCrossRefGoogle Scholar
  135. Stolerman IP, Chamberlain S, Bizarro L, Fernandes C, Schalkwyk L (2004) The role of nicotinic receptor alpha 7 subunits in nicotine discrimination. Neuropharmacology 46:363–371PubMedCrossRefGoogle Scholar
  136. Suebsasana S, Pongnaratorn P, Sattayasai J, Arkaravichien T, Tiamkao S, Aromdee C (2009) Analgesic, antipyretic, anti-inflammatory and toxic effects of andrographolide derivatives in experimental animals. Arch Pharm Res 32(9):1191–1200PubMedCrossRefGoogle Scholar
  137. Sufka KJ (1994) Conditioned place preference paradigm: a novel approach for analgesic drug assessment against chronic pain. Pain 58:355–366PubMedCrossRefGoogle Scholar
  138. Suzuki T, Misawa M (1995) Sertindole antagonizes morphine-, cocaine-, and methamphetamine-induced place preference in the rat. Life Sci 57:1277–1284PubMedCrossRefGoogle Scholar
  139. Suzuki T, Funada M, Narita M, Misawa M, Nagase H (1991) Pertussis toxin abolishes μ and δ opioid agonist-induced place preference. Eur J Pharmacol 205:85–88PubMedCrossRefGoogle Scholar
  140. Suzuki T, Funada M, Narita M, Misawa M, Nagase H (1993) Morphine-induced place preference in the CXBK mouse: characteristics of μ opioid receptor subtypes. Brain Res 602:45–52PubMedCrossRefGoogle Scholar
  141. Ther L, Lindner E, Vogel G (1963) Zur pharmakodynamischen wirkung der optischen isomeren des methadons. Dtsch Apoth Ztg 103:514–520Google Scholar
  142. Tsuji M, Nakagawa Y, Ishibashi Y, Yoshii T, Takashima T, Shimada M, Suzuki T (1996) Activation of ventral tegmental GABAB receptors inhibits morphine-induced place preference in rats. Eur J Pharmacol 313:169–173PubMedCrossRefGoogle Scholar
  143. Turenne SD, Miles C, Parker LA, Siegel S (1996) Individual differences in reactivity to the rewarding/aversive properties of drugs: assessment by taste and place conditioning. Pharmacol Biochem Behav 53:511–516PubMedCrossRefGoogle Scholar
  144. Tzschenke M (1998) Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 56:613–672CrossRefGoogle Scholar
  145. Van der Kooy D (1987) Place conditioning: a simple and effective method for assessing the motivational properties of drugs. In: Bozarth MA (ed) Methods of assessing the reinforcing properties of abused drugs. Springer, New York/Berlin/Heidelberg, pp 229–240CrossRefGoogle Scholar
  146. van Heest A, Hijzen TH, Slangen JL, Oliver B (1992) Assessment of the stimulus properties of anxiolytic drugs by means of the conditioned taste aversion procedure. Pharmacol Biochem Behav 42:487–495CrossRefGoogle Scholar
  147. VonVoigtlander PF, Lewis RA (1983) A withdrawal hyperalgesia test for physical dependence: evaluation of μ and mixed-partial opioid agonists. J Pharmacol Methods 10:277–282PubMedCrossRefGoogle Scholar
  148. Way EL (1993) Opioid tolerance and physical dependence and their relationship. In: Herz A, Akil H, Simon EJ (eds) Handbook of experimental pharmacology, vol 104, Opioids II. Springer, Berlin/Heidelberg/New York, pp 573–596 (Chap 53)Google Scholar
  149. Way EL, Loh HH, Shen FH (1969) Simultaneous quantitative assessment of morphine tolerance and physical dependence. J Pharmacol Exp Ther 167:1–8PubMedGoogle Scholar
  150. Weeks JR, Collins RJ (1987) Screening for drug reinforcement using intravenous self-administration in the rat. In: Bozarth MA (ed) Methods for assessing the reinforcing properties of abused drugs. Springer, New York/Berlin/Heidelberg, pp 35–43CrossRefGoogle Scholar
  151. Woods JH, France CP, Winger G, Bertamio AJ, Schwarz-Stevens K (1993) Opioid abuse liability assessment in rhesus monkeys. In: Herz A, Akil H, Simon EJ (eds) Handbook of experimental pharmacology, vol 104, Opioids II. Springer, Berlin/Heidelberg/New York, pp 609–632 (Chap 55)Google Scholar
  152. Woolverton WL, Nader MA (1990) Experimental evaluation of the reinforcing effects of drugs. In: Adler MW, Cowan A (eds) Testing and evaluation of drugs of abuse, vol 6, Modern methods in pharmacology. Wiley, New York, pp 67–79Google Scholar
  153. Woolverton WL, Schuster CL (1983) Intragastric self-administration in rhesus monkeys under limited access conditions: Methodological studies. J Pharmacol Methods 10:93–106PubMedCrossRefGoogle Scholar
  154. Yokel RA (1987) Intravenous self-administration: response rates, the effects of pharmacological challenges, and drug preference. In: Bozarth MA (ed) Methods for assessing the reinforcing properties of abused drugs. Springer, New York/Berlin/Heidelberg, pp 1–33CrossRefGoogle Scholar
  155. Yoshimura K, Horiuchi M, Konishi M, Yamamoto KI (1993) Physical dependence on morphine induced in dogs via the use of miniosmotic pumps. J Pharmacol Toxicol Methods 30:85–95PubMedCrossRefGoogle Scholar
  156. Yoshinaga K, Horii T, Hamano H, Eta R, Ozaki T, Orikawa Y, Yoshii K, Kawabata Y, Hori Y, Seto K, Takei M, Kuraishi Y (2010) Pharmacological evaluation of analgesic effects of the cholecystokinin2 receptor antagonist Z-360 in mouse models of formalin- and cancer-induced pain. Biol Pharm Bull 33(2):244–248PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  1. 1.Center for Sensory-Motor Interaction, Department of Health Science and Technology, School of MedicineAalborg UniversityAalborg EDenmark

Personalised recommendations